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FOCUS REVIEW
This special collection of papers on the topic of
placebos features diverse contributions from leading
researchers. We are privileged to benefit from the
perspectives of John Kihlstrom, Elizabeth Loftus and
James Fries, Pesach Lichtenberg, and Irving Kirsch. In
this commentary we contextualize the different
accounts within an overarching whole.
While most contributors to this MJM Focus Reviews
section are non-physicians, placebo research is a field of
great importance to any health care professional.
Although scholarly definitions abound (1), most
practitioners loosely regard the placebo effect as any
treatment that improves a symptom or disease but lacks
specific effectiveness for the condition being treated
(2).As we demonstrate below, the placebo effect is both
powerful and inherent in any clinical interaction (3). In
addition, the patient-practitioner relationship is a
significant component of the psychosocial context of
treatment, because health care workers communicate
important information to the patient through their
words, attitudes and demeanor (4). Use of placebos,
therefore, presents a didactic, philosophical, ethical, and
practical challenge for most physicians.
PLACEBOS AND PSYCHOSOCIAL FACTORS
IN MEDICINE
Placebos exemplify the link between psychosocial
factors and physiological processes. They bind
psychology to the techniques of neuroscience and
medicine (5, 6) and are beginning to connect physiology
to the social sciences (7-9). Outlining the current
inadequacies of medicoscientific reductionism in
relation to the relative merits of social science,
Kihlstrom’s piece nicely complements that of Raz &
Guindi on “Placebos and Medical Education.”
Individuals under the influence of a charismatic
authority can have bodily experiences that many
professionals would consider “all in the head.” Such
phenomena form an important element of many of the
world’s healing traditions, ranging from shamanism and
possession cults to Christian healing practices (10, 11).
The King’s Touch (KT), for example, refers to a
medieval belief that illness could be cured by the touch
of a divinely anointed monarch (12). Following the
introduction of the practice to Western Europe by
Edward the Confessor, kings in both France and
England healed patients by the laying on of hands, with
specific diseases (e.g., tuberculosis of the neck)
reportedly being especially amenable to their touch
(13). By the 17th century, KT had extended well beyond
the throne. Irish healer Valentine Greatrakes – aka “The
Stroker” – was able to amass thousands of clients, with
“his barns and outhouses crammed with innumerable
specimens of suffering humanity” (14). While
Greatrakes probably practiced a layman’s form of
psychotherapy that had previously been restricted to
members of the ruling class (15), modern science
speciously dismisses KT as preposterous. One Nobel
Laureate, for example, claimed that chicken soup might
be a more credible source of healing than KT because
ingesting soup may have chemical effects while it
seems impossible for the symbolic act of KT to exert
influence on the body (16). However, suggestion can
indeed bring about veridical physiological changes (17-
19).
Kihlstrom’s prominent investigations into hypnosis,
cognitive, clinical and personality psychology, and
health research put him in a unique position to comment
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on the social science of placebos. His piece is the
backbone of this special issue and establishes the milieu
for the other papers.
PLACEBOS IN MEDICAL PRACTICE
While commonly used by physicians in the clinical
setting prior to the 19th century, placebos fell out of
favor with the emergence of modern medicine (20).
Over the past decade, however, our knowledge of the
neural correlates of placebo mechanisms has greatly
increased, rekindling the placebo “flame” anew (21).
While bioethical issues shroud the use of placebos in
evidence-based medicine (2), some clinicians, mostly
academic physicians, appreciate the relative merits of
placebos and capitalize on their mind-body therapeutics
(22).
In his piece, Lichtenberg provides a glimpse into the
use of placebos in clinical settings. Many readers may
repudiate the use of inert treatments outside of research,
but such practices abound in medical care. Placebos
have been around for many years and are likely to
persist at least a while longer. Modern physicians will
do well to appreciate their foibles and virtues.
Studies, including recent research efforts, provide
evidence for the use of placebos in clinical contexts. A
survey of head nurses in a Connecticut health district
evaluated the status of placebos within the hospital
setting and found that 44% of respondents reported that
placebos were currently being used in their unit or that
placebos had been used within the past six months (23).
In another study aiming to determine knowledge and
patterns of placebo use, researchers sent surveys to
house officers and registered nurses (RNs) working in
two university teaching hospitals in the U.S. (24).
Seventy-eight percent of physicians who responded had
ordered at least one placebo as a painkiller, while 82%
of RNs had administered at least one placebo as a
painkiller. In Canada, researchers surveyed doctors and
nurses from the Victoria General Hospital in Halifax to
assess their knowledge of and attitudes towards
placebo, as well as their patterns of placebo use (25).
Eighty percent of both the RNs and physicians reported
having administered a placebo during their time at the
hospital, with 91% of the placebos consisting of saline
injections. In yet another study examining the frequency
of placebo use within nursing clinical practice,
researchers found that among 263 respondents, 178
(68%) had administered a placebo to patients; however,
only 12% had done so within the last year (26). In
Denmark, a survey of 772 physicians found that among
the 503 respondents, 86% of the general practitioners,
54% of the hospital doctors, and 41% of the private
specialists reported using placebo interventions at least
once within the last year (27). In a separate study
probing the frequency of placebo administration among
physicians and nurses in Israel, researchers found that
53 out of 89 respondents reported prescribing placebos,
33 of whom said they had prescribed them as often as
once a month (28). Finally, a more recent study found
that academic physicians in the Chicago area used
placebos in everyday clinical practice (22). Forty five
percent of these physicians surveyed reported
administering placebos, though 96% believed that
placebos have a therapeutic effect. Despite this
evidence that physicians are prescribing placebos (22,
28), no specific protocol currently governs their clinical
use.
Following up on recently published efforts (22, 27,
28), we have put together a web-based questionnaire
aiming to survey knowledge, beliefs, patterns of use,
and attitudes among health care professionals
concerning placebos. With this tool we hope to probe
the way clinicians and medical students construe
placebos and the extent to which these individuals use
placebos in clinical practice. We expect that our
findings will elucidate the prevalence and impact of
placebos in medical practice. We encourage you to visit
http://tinyurl.com/PlaceboSurvey and fill out a short
anonymous questionnaire to assess beliefs, patterns of
use, and attitudes concerning placebos. We hope to
provide results of our survey before long.
PLACEBOS AND THE CONSENT FORM
Even if clinical use of placebos remains relatively
widespread, a dramatic change over the past decades
makes this practice increasingly difficult to discuss or
acknowledge. With the rapid growth of legal and
administrative regulations affecting medical practice
and decision-making since the 1960s, as well as the
enshrinement of patient autonomy as an ethical norm in
medicine, the therapeutic use of placebos has become
something of a dirty secret (29, 30). At the heart of this
bureaucratic management of clinical ethics is the idea of
informed consent. Early proponents of clinical and
research ethics questioned whether complete consent
was ever realizable, and argued that responsible
clinicians and investigators represent a “far more
dependable safeguard than consent” (31-33). However,
the recent tendency is to ensure consent by exposing
patients to ever-more compendious accounts of possible
side-effects and risks, however minor or unlikely. This
trend takes on a particularly extreme form in the United
States, where a notably litigious culture fosters a strong
risk-aversion tactic among institutions providing
medical care. Thus, the consent form has turned into the
virtual opposite of the placebo.
If consent forms represent the apogee of transparency
and rational choice, placebos seem to be an apparentlyMcGill Journal of Medicine 208 2008
inevitable prelude to deceit. As Loftus and Fries argue,
however, even with increased reliance on bureaucratic
tools such as consent forms, the purview of suggestion
and expectation – core placebo components – continues
to thrive. In fact, the insistence on full disclosure
introduces a new, generally unappreciated variant of
suggestion into our midst. In their unpublished pilot
study, Loftus and Fries show that patients who sign
consent forms describing side effects (some of which
are invented by the researchers) do in fact experience
those side effects in response to placebo. Such negative
responses (i.e., “nocebo effects”) overlap with certain
placebo phenomena (34, 35). Moreover, that the act of
reading and signing a form is a source of suggestion
underscores the range of factors which can produce
physiological effects without physical or chemical
intervention.
In the minds of many contemporary practitioners who
thrive on the ideals of patient autonomy and self-
realization, placebos belong to an era when paternalism
and beneficence characterized the therapeutic
relationship. Two opposing stances, however, seem to
guide even the beneficial effects of modern placebos: a
passive current of “being cared for” and an active one of
“caring for oneself” (36). It is likely that both have
physiological effects. After all, mere observation often
induces behavioral changes in patients, even in the
absence of active clinical interventions – the
“Hawthorne effect” (37).
SHOULD WE DEVELOP PLACEBOS FOR
MEDICAL PRACTICE?
Sometimes, when clinical trials demonstrate that an
experimental treatment is comparable to a placebo,
clinicians conclude that the treatment is unsuitable for
prescription. Such a conclusion, however, is
incongruous with the notion that receiving nothing is
appropriate or preferable. For example, in several
randomized double-blind trials, non-prescription cough
suppressants and expectorants have failed to show
increased effectiveness over placebo (38). Many
pediatricians refuse to recommend over-the-counter
cough therapy because they think it is ineffective and
potentially harmful (39). Such practice, however,
disregards the placebo effect. In other words, non-
prescription cough therapy probably is helpful for some
individuals because of its placebo effect. For this
reason, the medical community may wish to consider
identifying therapies that work as a result of placebos.
Such interventions should have minimal side-effects
and be inexpensive; yet should be unusual and costly
enough to raise patients’ expectations regarding
effectiveness (40).
On the other hand, some clinicians continue to
prescribe certain medications even if their effects are
comparable to placebos. Typically, the reluctance to
stop prescribing medication is due to force of habit, a
desire to please the patient, or the belief that anecdotal
experience provides sufficient evidence for its efficacy.
For example, as Kirsch reports in this issue, despite
ample evidence that anti-depressants provide scant
benefit beyond a placebo effect, many clinicians insist
on continuing their use.
PLACEBOS AND MEDICAL EDUCATION
Western medicine follows largely in the footsteps of
Descartes, whose mind-body dualism allowed
physicians to treat the body without worrying about the
potential effect of their interventions on the soul and
made the practice of medicine more acceptable to
theologians of the time (41). Modern students often
learn to construe the body as an isolated entity,
unaffected by the mind or social environment (42).Thus
our medical system continues to operate from the point
of view that we can understand and treat disease in
biological terms, largely neglecting the effects of the
mind on the body or vice versa.
Even if some medical students and physicians
acknowledge that psychology might matter to clinical
practice, few view psychology as a science on par with
biology. Instead, they consider psychology and the
other social sciences to be “soft” while regarding
themselves as operating in the domain of “real,” hard
science (43). Whereas a reduction from biology to
chemistry to physics may seem viable to many
individuals, a reduction from psychology is knottier.
Nonetheless, one can understand psychosocial factors
only by stepping outside the exclusively biological
paradigm of contemporary medicine and taking a
serious look at psychology and other social sciences.
Raz and Guindi explore placebos from the vantage
point of current medical education. Fortunately, medical
students who appreciate the notion of placebo in
therapy may be able to build their careers on a
foundation that encompasses mind-body interactions.
Thus, future medical practitioners will greatly expand
their knowledge base and clinical applications
involving placebos.
OTHER ASPECTS
Placebos currently occupy a paradoxical position in
both lay and scientific discourse, as a renewed interest
in the mechanisms underlying various body-mind
phenomena vies uneasily with skepticism of non-
biological explanations in medicine (1). An example of
this tension was the powerful and conflicting set of
reactions to a meta-analysis of clinical trials claiming
that placebo effects are minimal or non-existent (44).Placebos in Medicine 209 Vol. 11 No. 2
Multiple researchers have critiqued many aspects of this
controversial meta-analysis (45-48), and re-analyses of
the data yielded findings of a “robust” placebo effect
(49) setting off a flurry of rebuttals and debates (50-52).
Criticisms aside, this contentious meta-analysis is
extremely telling in that the assumptions it makes about
placebos are similar to those made by much of
mainstream medicine. For example, it confuses
confirmatory with exploratory explanations and treats
meta-analyses of data from randomized clinical trials as
one of the most authoritative ways of demonstrating
effectiveness while it ignores experiments which
demonstrate the mechanisms underlying placebo
responses (53, 54). Indeed, epistemological issues
explain one important source of difficulty for
contemporary medicine in acknowledging placebo
responses (3).
Contemporary medicine elides most aspects of the
physician-patient encounter in its explanations of cure,
but it also fosters an ideal – a fantasy in which
biological disease entities thrive without the messiness
of psychology, meaning, or culture. In this regard,
Kihlstrom’s allusion to the Star Trek Feinberger is most
appropriate. The field of psychiatry provides an
excellent example of this tendency.
While psychiatry used to engage with the social
sciences for much of the 20th century (55, 56), over the
past twenty-five years a biological paradigm has
become more dominant, reducing psychological and
psychiatric explanations of behavior to neurobiology
(57). Thus for many professional leaders, including the
scientific directors of the Canadian and U.S. national
institutes of mental health, the future of psychiatry lies
in its becoming “a clinical neuroscience discipline”
(58). Such reductionism, however, often makes it
difficult for clinicians to acknowledge, understand and
treat patients whose “non-specific” symptoms deviate
from textbook characterizations. This issue is especially
poignant as efforts to revise the Diagnostic and
Statistical Manual of Mental Disorders (DSM) will
soon result in DSM-V (59, 60). Recent findings from
psychological experiments and neuroimaging studies
reveal that differences in cultural background and
language mirror divergent cognitive styles (61). In
addition, numerous experimental, clinical and
ethnographic accounts reveal that beliefs and
expectations are likely to have effects on the ways that
people experience bodily sensations and symptoms (62,
63). Culturally-specific attributions of symptoms may
shape a person’s expectations so as to amplify
experiences of particular somatic or psychological
sensations, and it therefore seems that culture can frame
symptoms (64).
We can illustrate how culture can shape biology.
Lactase, the enzyme necessary to digest milk, provides
a good example into this process. While the majority of
adult humans rarely produce lactase, descendants of
populations which domesticated cattle and used milk as
a central food source are more likely to carry a genetic
variation allowing lactase to persist into adulthood (65,
66). Similarly, among Vietnamese and Cambodian
patients in the U.S., researchers have described
culturally-specific forms of panic (67, 68). Another
example from Japanese culture draws on the societal
value of aging females: menopausal women in Japan,
are less likely to experience the hot flashes and night
sweats that are widespread among older women in
North America (69, 70). (Anthropologists have ruled
out the possibility that these differences are due to
eating more soy (i.e., ingesting chemicals that closely
mimic the action of estrogen). Thus it is at least possible
that this difference may have to do with the fact that
Japanese culture promotes a different understanding of
what it means to be an older woman and that the body
is complying with this cultural expectation). A final
example of cultural suggestion comes from the history
of hypnosis which have changed in ways that reflect
changing social expectations and mores (71): while the
18th century patients of Anton Mesmer convulsed
violently as they felt animal magnetism racing through
their bodies; those hypnotized by the Marquis de
Puysegur entered a “sleep-walking” state; and Jean-
Martin Charcot’s patients were and behaved as
hysterics.
Indeed, the effect that culture has on behavior is
consistent with our modern concept of suggestion – a
powerful, psychological influence that affects
individuals through their subjective beliefs and
experiences. Our bodies seem to have a culture and a
history (64). If we want to develop a medicine that is
adequate to the needs of patients, we must acknowledge
that beyond physiology, biology is a co-construct of
cultural phenomena. Thus, our understanding of illness
and cure must draw on the social as well as the life
sciences.
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